| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.23 | 8e-06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.33 | 1e-05 |